DarpanJoshi, GauravAmrutkar, Suyog M.Baviskar, Ashish T.Kler, HarveenSingh, SandeepBanerjee, Uttam C.Kumar, Raj2017-08-082024-08-132017-08-082024-08-132016Darpan, G Joshi, SM Amrutkar, AT Baviskar, H Kler, S singh, UC Banrjee, R Kumar* Synthesis and biological evaluation of new 2, 5- dimethylthiophene/furan based N-acetyl pyrazolines as selective topoisomerase II inhibitors. RSC Advance, 6(18), 14880-14892Online - 2046-206910.1039/c5ra25705khttp://10.2.3.109/handle/32116/284Based on the reported pharmacophores as topoiomerase inhibitors, 2,5 dimethylthiophen/furan based N-acetyl pyrazolines were designed and envisaged as topoisomerase inhibitors. The target compounds were synthesized and tested in vitro against human topoisomerases in decatenation, relaxation, cleavage complex and DNA intercalation assay. Out of 29 compounds, three (10, 11 and 29) showed potent and selective toposiomerse II inhibitory activity with no intercalation with DNA. Further, molecular docking studies also endorsed them as ATP dependent topoisomerase II catalytic inhibitors. These compounds exerted potential anticancer effects on breast, colon, lung and prostate cancer cell lines at low micromolar level as compared to etoposide and low toxicity to normal cells. Apart from the topoisomerase II inhibition, these compounds also induced the reactive oxygen species (ROS) level in cancer cells. The cell cycle analyses showed their apoptotic effect at G1 phase.enArticlehttp://pubs.rsc.org/en/Content/ArticleLanding/2016/RA/C5RA25705K#!divAbstract